No quarterly revenue total was found in GP-Act III Acquisition Corp.'s SEC filings.
GP-Act III Acquisition Corp. (GPAT) files with the SEC under industry code 6770, Blank Checks.
Revenue
—
Net income
$290,121
-90.3% vs year-ago quarter
Operating cash flow
$-188,842
-45.0% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- GPAT (Nasdaq), GPATU (Nasdaq), GPATW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1834526
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$1.5M | -$565,279 | -$84,204 | -$126,328 | -$141,334 |
| Net income | $290,121 | $2.2M | $2.9M | $3.1M | $3.0M |
| Operating cash flow | -$188,842 | -$108,232 | $10,832 | -$100,861 | -$130,258 |
| Total assets | $98.4M | $312.1M | $309.4M | $306.5M | $303.4M |
| Total liabilities | $16.4M | $15.3M | $14.7M | $14.7M | $14.7M |
| Stockholders' equity | -$16.3M | -$15.0M | -$14.5M | -$14.4M | -$14.3M |
| Cash and investments | $98.2M | $312.0M | $309.3M | $306.3M | $303.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 4, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
|
May 14, 2026 | May 13, 2026 |
| 8-K |
Current report
Material agreement
|
May 13, 2026 | May 12, 2026 |
| 8-K |
Current report
Other events
|
May 7, 2026 | May 7, 2026 |
All 85 GP-Act III Acquisition Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.